FDA Grants Emergency Use to Monoclonal Antibody Combo for COVID FDA Grants Emergency Use to Monoclonal Antibody Combo for COVID

Bamlanivimab and etesevimab can be administered in combination to people who test positive for COVID-19 and are at higher risk for progression to severe disease.FDA Approvals
Source: Medscape Pediatrics Headlines - Category: Pediatrics Tags: Infectious Diseases News Alert Source Type: news